Studying the effect of herbal supplements on reducing inflammation and the healing process of patients who are candidates for thoracic surgery

Comparison of the Effect of Viniscin Barij Herbal Supplement and Placebo on Inflammatory Markers in Patients Undergoing Thoracotomy Surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250923067343N1

Enrollment

Registered

2025-11-17

Start date

2025-11-22

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory indices after thoracotomy. Infection following a procedure

Interventions

Intervention 1: The intervention group will take the Viniscin Barij herbal supplement for 3 days, twice daily (every 12 hours) before surgery. Viniscin Barij is provided in 335 mg capsules and is comp

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18 to 70 years Consent to enter the study No previous history of thoracotomy (lobectomy) surgery

Exclusion criteria

Exclusion criteria: Patient dissatisfaction. Patients undergoing chemotherapy Patients taking corticosteroids Heart failure, obstructive pulmonary disease, autoimmune diseases.

Design outcomes

Primary

Measure	Time frame
Severity of post-thoracotomy inflammation. Timepoint: Before and after surgery. Method of measurement: Laboratory blood tests and standard hospital checklists.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKobra Rafie badi

Shahid Beheshti University of Medical Sciences

abrisham57@gmail.com+98 21 2712 3008

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026